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Introduction. The incidence of genetic blood disease in Bahrain has declined gradually since 1984 when the Ministry of Health
(MOH) instituted a prevention campaign. The national NBS program for hemoglobinopathies was started in May 2007, ﬁnanced
by the national budget. Setting. Genetics department, Salmaniya Medical Complex, MOH, Bahrain. Methodology. The genetics,
nursing, pathology, and pediatric departments were involved in the study. This service was oﬀered to all infants. Cord blood
samples were collected at birth and were then sent to the laboratory. Results. During 3.5 years after the program was implemented,
we screened 38,940 newborns (NBs), of which 17,375 were screened in 2008, 10,248 in 2009, and 11,317 in 2010. The number of
aﬀected NBs was 128 in both 2007 and 2008, 58 in 2009, and 47 in 2010, as the average number of aﬀected NBs in 2010 was 4
per month. The incidence of aﬀected NBs was found to be 0.7% in 2008, 0.6% in 2009, and 0.4% in 2010. Conclusion.N B Si sa n
essential step for the early diagnosis and treatment of aﬀected NBs, future recurrence of the disease in the same family. In Bahrain,
the number of aﬀected NBs has declined by 75% during the last 20.
1.Introduction
Bahrain comprises an archipelago of 36 islands, with an area
of 717.5km2, located in the Arabian Gulf. Saudi Arabia is
situated to the west and Qatar to the east. The estimated
population of Bahrain in 2010 was 1,039,297. The 2001
census data showed that the population of Bahrain was
646,551 in 2007, of which Bahraini nationals constituted
50.7% and non-Bahrainis constituted 49.3%. Most Bahraini
Arabs are originally from the Arabian Peninsula. The crude
birth rate was estimated to be 15.4/1000 individuals, whilst
the infant mortality rate was 83/1000 live births in 2007 [3].
Genetic blood diseases (GBDs) are common in Bahrain
and in all Middle Eastern countries [4, 5]. Bahrain is the
ﬁrst country in the Middle East region to tackle this issue
since 1984 when the Ministry of Health (MOH) of Bahrain
recognized the importance of controlling these diseases. In
1984, the ﬁrst genetics clinic was established, which began
educational campaigns. Information booklets were prepared
and distributed widely in an attempt to increase awareness
about these diseases among the public.
The campaigns, which have been conducted since 1980,
focused on public awareness, education, and screening
pertaining to antenatal issues and premarital services (1993),
students and premarital issues (1998), newborns (2007), and
prenatal testing [6].
In 1991, the Bahrain Hereditary Anemia Society was
formedwiththeaimofpromotingawarenessamongthepeo-
ple of Bahrain. Molecular laboratories have been established
in the main hospitals to study genotype-phenotype cor-
relations, and the mutations that cause GBDs have been
characterized.
We obtained support from religious scholars, and the
parliament. In 2004, the king of Bahrain issued a law of
premarital counseling. In 2007, the ministerial cabinet ap-
proved the budget for the newborn screening (NBS) pro-
gram.
Several teams were involved in the campaign, including
clinical geneticists, primary health care workers, pediatri-
cians, hematologists, molecular geneticists, school teachers,
students, religious scholars, policymakers, nurses, and tech-
nicians.2 Advances in Hematology
Table 1: Aﬀected newborns with sickle cell disease in 2010.
Month No. SCD Total newborn Percentage
January 4 968 0.41%
February 4 831 0.48%
March 4 854 0.46%
April 2 875 0.22%
May 6 944 0.63%
June 1 874 0.11%
Juley 5 996 0.5%
August 3 1007 0.29%
September 7 987 0.7%
October 8 1033 0.77%
November 3 958 0.3%
December 0 990 0
Total 47 11317 0.41%
The campaign continued for approximately 20 years.
Variousissuesrelatedtoethical,legal,andsocialimplications
(ELSI), such as informed consent, privacy, equity, conﬁden-
tiality, and prevention of stigmatization and discrimination,
were addressed during the screening programs.
The NBS program is a well-recognized health program
aimed at early identiﬁcation of infants who are aﬀected by
certain genetic, metabolic, or infectious conditions. Early
identiﬁcation of these conditions is particularly crucial
as timely intervention can signiﬁcantly reduce morbidity,
mortality, and associated disabilities in aﬀected infants and
savethousandsofbabiesfrommentalretardation,death,and
other complications.
This paper describes the NBS program for sickle cell
disease (SCD) and sickle cell thalassemia in Bahrain and
analyzes the results of the last 3.5 years of screening service.
2.MaterialandMethods
Thescreeningisoﬀeredtoallinfantswhoaredeliveredinthe
MOH maternity units. An explanatory leaﬂet detailing the
purpose, process, and outcomes of the screening service was
provided to the parent(s) by midwives before screening. The
decision to opt out of testing was documented.
A questionnaire for each newborn was completed by a
nurse. The form included data regarding demographic char-
acteristics, parental age group, and consanguinity and was
coded for computerization.
3. Sample
The cord blood of the infants was collected at birth and
posted to the central laboratory for testing.
Sample analysis: high-performance liquid chromatog-
raphy according to Eastman et al. 1996 [6]w a su s e dt o
perform electrophoresis on the cord blood samples to
detect the hemoglobin fractions present, and a ﬂuorescent
screening technique, according to Jiang et al. 2003 [7], was
used to detect glucose-6-phosphate dehydrogenase (G6PD)
deﬁciency. In cases where an abnormal band was suspected,
a second-line test isoelectric focusing was performed to con-
ﬁrm the presumptive diagnosis. Hematologists interpreted
the results, and, in few cases, diagnosis could be achieved
only by using DNA analysis. All the results obtained were
sent by the laboratory technicians to the genetics department
where further action to be taken depended on the categories
of the results as follows.
For NBs with SCDs or any other hematological condi-
tions, which required follow-up, the parents were informed
by personal contact and they were asked to visit the clinic,
where a conﬁrmatory test was performed. The newborn was
referred to a pediatrician for management and follow-up if
the suspected condition was conﬁrmed.
The infant’s family wasreferred to the maternal and child
health facility if no abnormality was detected or if the infant
was heterozygous for a hemoglobin variant.
4. Results
The number of aﬀected newborns per month in 2010 is
shown in Table 1, while the number and percentage of af-
fected newborns per year during 2007–2010 are shown in
Table 2.
The decline in the incidence of SCD between 1985 and
2010 is shown in Figure 1.
5. Discussion
TheMOHinBahrainrecognizedthatNBSisanessentialstep
toward the early diagnosis and treatment of genetic diseases
amongnewborns,foravoidingfurthercomplicationsandfor
advising parents so as to prevent future recurrence of these
diseases in the same family.
Many pilot studies were performed before starting the
program at the national level. The results of these studies
mandate this program because of the high rate of hemo-
globinopathies in the community [8].Advances in Hematology 3
Table 2: Aﬀected newborns with sickle cell disease per year during 2007 to 2010.
2007 and 2008 2009 2010
NO % NO % NO %
SCD 123 0.7% 58 0.56% 47 0.41%
SCT 1969 11.3% 1605 15% 1673 14.7%
Normal 15283 88% 8585 83.7% 9644 85%
Total 17375 10248 11317
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Figure 1: Decline in the newborns incidence of sickle cell disease
between 1985 and 2010.
We tried to implement all the factors necessary for the
success of a national NBS program such as making NBS a
government priority, providing funding for NBS, ensuring
general public acceptance, and ensuring the cooperation of
all health practitioners and family physicians.
The screening service started in mid-2007, after obtain-
ing approval from the MOH and allocation of the national
budget. Many departments cooperated for implementing the
program; it involved the genetics department, pathology
department,maternalandchilddepartment,nursingdepart-
ment, and the health information directorate.
The senior staﬀ trained nurses and technicians for
collecting and testing blood samples.
The NBS program can be considered as an audit for the
previous campaign that dealt with controlling genetic dis-
eases. Every newborn aﬀected was studied to ﬁnd whether
he/she belonged to a family with a previous case of SCD
or to a new family, and advice was given regarding future
pregnancy and care for the aﬀected newborn.
Wenoticed agradualreductioninthenumberofaﬀected
newborns, as shown in Figure 1, from 2.1% in 1985 to 0.4%
in 2010. This may indicate a gradual decline in disease
frequency, which was most probably due to the increased
awareness among the people of Bahrain that was a result
of the educational and awareness campaign started approxi-
mately 20 years ago.
A previous molecular study showed that approximately
90% of patients had a mild form of SCD. DNA analysis has
proved the presence of the Asian haplotype as the common
haplotype. This mutation is known to be associated with a
high level of fetal hemoglobin (HbF), a situation similar to
that in the eastern province of Saudi Arabia [7, 9–11].
In the future, we expect that technological advances will
continue to signiﬁcantly impact the sensitivity, speciﬁcity,
and scope of the NBS programs. Screening for other dis-
orders such as hypothyroidism, blindness, and deafness has
already started in Bahrain. A pilot study on metabolic
disorders is also being planned.
6. Conclusion
This study shows that the incidence of SCD was <0.5%
in 2010 among the study group, which is lower than that
reported in previous studies conducted in Bahrain. This
indicated a gradual decline in disease frequency, which may
be due to the high awareness among the people of Bahrain
that was a result of the educational and awareness campaign
started approximately 20 years ago. With the continuation
of education and awareness campaigns, carrier screening,
and premarital services, we expect the number of aﬀected
newborns to reduce tremendously over the next few years.
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